MedPath

Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease

Not Applicable
Completed
Conditions
IgG4-related Disease
Interventions
Biological: extra blood draw samples
Registration Number
NCT02899039
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Brief Summary

IgG4-related disease is a rare and very recently identified pathology, whose frequency is certainly underestimated.

The clinical presentation varies among affected organs, and most often, patients have at least three organ damage.

These organs exhibit tissue infiltration mononuclear polymorphic cells with often severe fibrosis progression resulting in a loss of function.

The biomarker, though not specific, is a polyclonal elevated serum IgG4, and histological marker, currently held by several teams, is the presence within the inflammatory infiltrate, of a predominance of IgG4-expressing plasma-cells with a relative plasma-cells IgG4 + / IgG +\> 50% on tissue immunostaining.

The investigators project provides a global assessment of T lymphocyte abnormalities and specifically the TFH (Follicular Helper) during this IgG4-related disease compared to so-called groups "control" subjects suffering from Sjogren syndrome or healthy subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • IgG4-related disease patients or
  • Sjogren syndrome patients or
  • Healthy subjects
Exclusion Criteria
  • Presence of autoimmune or inflammatory associated disease
  • Age less than 18 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Healthy controlsextra blood draw samplesHealthy subjects
IgG4-related diseaseextra blood draw samplesSubjects suffering from IgG4-related disease
Sjögren syndromeextra blood draw samplesSubjects suffering from Sjôgren syndrome
Primary Outcome Measures
NameTimeMethod
Proportion of Follicular Helper T cells (CD4 + CXCR5 + ICOShigh) in the blood36 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

APHM

🇫🇷

Marseille, France

© Copyright 2025. All Rights Reserved by MedPath